Fol­low­ing low­er-than-ex­pect­ed prof­its, Evotec plans to cut costs, com­pletes CEO search

Evotec an­nounced a “re­set” to its busi­ness plan as it re­port­ed fi­nan­cial re­sults Wednes­day, fol­low­ing a year in which many con­tract drug man­u­fac­tur­ers have strug­gled.

The Ger­man com­pa­ny al­so an­nounced that Chris­t­ian Wo­jczews­ki will join as its new CEO at the start of Ju­ly. Wo­jczews­ki, who was pre­vi­ous­ly the CEO of Dutch health­care com­pa­ny Mediq, will re­place Evotec’s in­ter­im leader Mario Poly­wka. Poly­wka served as Evotec’s chief op­er­at­ing of­fi­cer for 13 years un­til 2018, and took the in­ter­im CEO role in Jan­u­ary, when long­time Evotec head Wern­er Lan­thaler re­signed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER